Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.54
-0.16 (-1.26%)
Apr 24, 2026, 1:32 PM EDT - Market open
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $429.56 million as of April 24, 2026. Its market cap has increased by 49.86% in one year.
Market Cap
429.56M
Enterprise Value
236.96M
1-Year Change
49.86%
Ranking
Category
Stock Price
$12.54
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $429.56M, a decrease of -80.71%. That is a compound annual growth rate of -12.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 435.04M | -4.62% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 471.62M |
| Entrada Therapeutics | 470.52M |
| REGENXBIO | 470.23M |
| Palisade Bio | 468.78M |
| Lexeo Therapeutics | 466.01M |
| Invivyd | 449.66M |
| Climb Bio | 447.59M |
| Altimmune | 443.66M |